Aegis Lifesciences Private Limited

Surgi-ORC® Absorbable Haemostat: Features and Benefits
• Rapid Action: Haemostasis within 3-4 minutes• Absorbable: Completely absorbable• Biocompatible: No tissue reactions• Antibacterial: Low pH leads to the bactericidal effect• Adaptable: Can be cut into any desired dimension without fraying and applicable to various tissue thicknesses andsurgery sites• Easy to Use: Highly flexible and drapable; can be sutured• Ready to Use: Applied, laid on, held against or wrapped around the bleeding surface in dry form• Safer: No animal origin or collagen substances• Compliance: Compliance with United States Pharmacopoeia.
Why to use Surgi-ORC®How Does Surgi-ORC® Work?• The plant based natural cellulose dissolved and extruded as a continuous fiber (regeneration). The fabric made fromthese fibers has uniform chemical composition. The oxidized form of these fabrics shows high stability and fluidabsorption, when compared with cotton-based products• Surgi-ORC® Absorbable Haemostat is a sterile product made up of oxidized regenerated cellulose (polyoxyanhydro glucuronic acid)
• Surgi-ORC® Absorbable Haemostat has no animal or collagen additive substances and can be sutured and cutwithout any wear.
Haemostatic mechanism:
The mechanism of action of Surgi-ORC® is independent fromthe blood coagulation mechanism of the body. Surgi-ORC®absorbs the blood and forms a brown/black gelatinousmass, which aids clot formation at the site of application.This gelatinous mass acts as a physical matrix for theplatelets adherence. Platelets aggregation leads to theformation of a platelet-fibrin plug, hence, Haemostasis.

Additional Information:

• Item Code: SOO-0214
• Delivery Time: 7 Days
• Packaging Details: No. of Pieces Per Box 12

SURGISPON® is a sterile absorbable gelatin sponge with haemostatic effect suitable for the control of bleeding.
SURGISPON® is manufactured from highly purified neutral gelatin foam of uniform fine porosity which guarantees a favourable homeostasis. Gelatin sponge activates the thrombocytes at the moment blood comes in contact with the matrix of the sponge. It causes thrombocytes to release a series of substances which promote their aggregation at the same time as their surfaces change character, and enabling them to act as a catalyst for the formation of fibrin.
SURGISPON® provides haemostasis in surgical procedures to control capillary, venous and small arterial bleeding when binding, suturing or other conventional methods of control are impractical or ineffective.
SURGISPON® can be applied dry or moistened with sterile physiological saline.
SURGISPON® is pressed against the bleeding site and within a short time it adheres to the wound and control the bleeding. It is recommended to remove any excess SURGISPON® material from the operative field.
Haemostasis in 2 – 4 minutes Liquefies in 2 – 5 days in contact with mucosa Absorbs 35 times its own weight in blood an fluids Completely absorbed within 4 weeks pH-neutral 100% biodegradable Can be used dry or impregnated Available in sponge and powder form Compatible with pharmaceuticals

Additional Information:

• Item Code: 1
• Production Capacity: 5000000
• Delivery Time: 7Day

SURGISPON® Cardiovascular Patch
 
The SURGISPON® patch facilitates cardiovascular reconstructions and offers a wide range of features and benefits, including:
A Design to Minimize Bleeding:Advanced polymeric patch helps to seal the sutured area
Ease of Handling: Requires no rinsing before procedures, can easily be trimmed to the desired size, and can easily be accommodated by cardiovascular anatomy
Reliable Performance:Improved suture retention, low thrombogenicity, and resistance to aneurysmal dilation
Durability: Non-fraying with multi-directional strength

 
The SURGISPON® patch is designed for cardiovascular applications including cardiac, great vessel, and peripheral vascular repair and reconstruction. Advanced technology enables our Gelatin patch to seal around penetrating sutures and reduce suture line bleeding by a significant amount. This technology, combined with a low rate of restenosis, low thrombogenicity, improved suture retention, and multi-directional strength, sets the patch apart from the competition.